New Orleans, LA, United States of America

Gerald Billac

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Louisiana State University and Agricultural & Mechanical College. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gerald Billac: Innovator in Anti-Inflammatory Treatments

Introduction

Gerald Billac is a notable inventor based in New Orleans, Louisiana. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating inflammatory disorders. His work is characterized by a commitment to improving health outcomes through innovative solutions.

Latest Patents

Gerald Billac holds a patent for "Compounds and methods for treating inflammatory disorders." This invention features compounds and pharmaceutical compositions that possess anti-inflammatory properties. The patent also outlines methods for using these compounds or compositions to treat inflammatory disorders in subjects in need.

Career Highlights

Billac is affiliated with Louisiana State University and Agricultural & Mechanical College, where he continues to engage in research and development. His work has garnered attention for its potential impact on treating various inflammatory conditions, showcasing his dedication to advancing medical science.

Collaborations

Throughout his career, Gerald Billac has collaborated with esteemed colleagues, including Charles David Nichols and David E. Nichols. These partnerships have enriched his research and contributed to the success of his innovations.

Conclusion

Gerald Billac's contributions to the field of anti-inflammatory treatments highlight his role as an important inventor in the pharmaceutical industry. His innovative approaches continue to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…